Private Capital Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $7K | Hold |
230
| – | – | 0.01% | 1155 |
|
2022
Q1 | $8K | Buy |
230
+202
| +721% | +$7.03K | ﹤0.01% | 1358 |
|
2021
Q4 | $1K | Sell |
28
-85
| -75% | -$3.04K | ﹤0.01% | 1983 |
|
2021
Q3 | $5K | Sell |
113
-211
| -65% | -$9.34K | ﹤0.01% | 1598 |
|
2021
Q2 | $18K | Sell |
324
-207
| -39% | -$11.5K | ﹤0.01% | 1148 |
|
2021
Q1 | $40K | Buy |
531
+373
| +236% | +$28.1K | 0.01% | 746 |
|
2020
Q4 | $14K | Buy |
158
+3
| +2% | +$266 | ﹤0.01% | 1314 |
|
2020
Q3 | $9K | Buy |
155
+78
| +101% | +$4.53K | ﹤0.01% | 1358 |
|
2020
Q2 | $3K | Sell |
77
-37
| -32% | -$1.44K | ﹤0.01% | 1626 |
|
2020
Q1 | $3K | Buy |
114
+94
| +470% | +$2.47K | ﹤0.01% | 1618 |
|
2019
Q4 | $1K | Sell |
20
-95
| -83% | -$4.75K | ﹤0.01% | 1849 |
|
2019
Q3 | $16K | Buy |
+115
| New | +$16K | ﹤0.01% | 1292 |
|